Lab member attended the Shanghai-Xiamen Training Course on Advances in Endocrine and Metabolic Diseases
From May 23 to 24, 2026, Dr. Huixia Ren and students Xuejiao Wang, Yawen Deng, and Shi Zeng to Xiamen to participate in the 5th Shanghai-Xiamen Training Course on Advances in Endocrine and Metabolic Diseases. In the islet-focused session, Dr. Quan Zhang from the University of Oxford presented his work on metabolic memory in pancreatic delta cells and impaired glucagon secretion. Dr. Enming Zhang from Lund University discussed current progress and future perspectives on aging-dependent islet dysfunction. Dr. Qi Fu from the First Affiliated Hospital of Nanjing Medical University presented research on dietary load and islet metabolic adaptation. Dr. Yanyun Gu from Shanghai Jiao Tong University School of Medicine discussed the role of gut microbiota and bile acid metabolism in glucose-lowering interventions and the regulation of pancreatic β-cell mass. Dr. Mingyu Li from Xiamen University School of Pharmaceutical Sciences presented findings on glucagon receptor signaling and islet α-cell metabolism. Dr. Ning Chen from Zhongshan Hospital, Fudan University Xiamen Branch, introduced research on the improvement of islet function by GLP-1/GIP dual receptor agonists through restoration of β-cell identity. Dr. Huixia Ren reported in vivo imaging studies on the regulation of β-cell calcium oscillations and glycemic signal encoding by islet δ-α cell interactions. Overall, this session provided a focused overview of current research on islet cell function, intra-islet communication, metabolic adaptation, and therapeutic strategies targeting islet dysfunction.